Inhibition of Cytopathic Effect of Human Immunodeficiency Virus Type-1 by Various Phorbol Derivatives.
作者:Sahar El-Mekkawy、Meselhy Ragab Meselhy、Atef Abdel-Monem Abdel-Hafez、Norio Nakamura、Masao Hattori、Takuya Kawahata、Toru Otake
DOI:10.1248/cpb.50.523
日期:——
Forty-eight derivatives of phorbol (9) and isophorbol (14) were evaluated for their inhibition of human immunodeficiency virus (HIV)-1 induced cytopathic effects (CPE) on MT-4 cells, as well as their activation of protein kinase C (PKC), as indices of anti-HIV-1 and tumor promoting activities, respectively. Of these compounds, the most potent inhibition of CPE was observed in 12-O-tetradecanoylphorbol 13-acetate (8) and 12-O-acetylphorbol 13-decanoate (6). The former also showed the strongest PKC activation activity, while the latter showed no activity at 10 ng/ml. Both activities were generally observed in those phorbol derivatives with an A/B trans configuration, but not in the isophorbol derivatives with an A/B cis configuration. Acetylation of 20-OH in the phorbol derivatives significantly reduced the inhibition of CPE, as shown in 12-O-, 20-O-diacetylphorbol 13-decanoate (6a) (IC100=15.6 μg/ml) vs. compound 6 (IC100=0.0076 μg/ml), and 12-O-tetradecanoylphorbol 13,20-diacetate (8a) (IC100=15.6 μg/ml) vs. 12-O-tetradecanoylphorbol 13-acetate (8) (IC100=0.00048 μg/ml), except in the case of 12-O-decanoylphorbol 13-(2-methylbutyrate) (4) and phorbol 12,13-diacetate (9c). The reduction of a carbonyl group at C-3 abruptly reduced the inhibition of CPE, as observed in 3β-hydroxyphorbol 12,13,20-triacetate (9f) (IC100=500 μg/ml) vs. phorbol 12,13,20-triacetate (9d) (IC100=62.5 μg/ml). Although 8 was equipotent in the inhibition of CPE, and activation of PKC, both activities were abruptly decreased by the acetylation of 20-OH and methylation of 4-OH [as in 8a and 4-O-methyl-12-O-tetradecanoylphorbol 13,20-diacetate (8b), respectively]. On the other hand, its positional isomer (12-O-acetylphorbol 13-tetradecanoate (8c) showed neither activities. The removal of a long acyl group in 8 led to a substantial loss of both activities, as shown in phorbol 13-acetate (9b). Of the 12-O-acetyl-13-O-acylphorbol derivatives, the highest inhibition of CPE was observed in 6, which has a dodecanoyl residue at C-13. Both an increase and decrease in the number of fatty acid carbon chains resulted in significant reduction of the inhibition of CPE.
四十八种分子的phorbol(9)和isophorbol(14)被评估其对人类免疫缺陷病毒(HIV)-1诱导的细胞病变效应(CPE)在MT-4细胞上的抑制作用,以及其激活蛋白激酶C(PKC)的能力,分别作为抗HIV-1和肿瘤促进活性的指标。在这些化合物中,12-O-十四酸酯phorbol 13-醋酸酯(8)和12-O-乙酰phorbol 13-癸酸酯(6)显示出对CPE的最强抑制作用。前者也表现出最强的PKC激活活性,而后者在10 ng/ml时未显示活性。这两种活性通常是在具有A/B反式构型的phorbol衍生物中观察到的,而不是在具有A/B顺式构型的isophorbol衍生物中。对phorbol衍生物中的20-OH进行乙酰化显著降低了对CPE的抑制,正如在12-O-、20-O-二乙酰phorbol 13-癸酸酯(6a)(IC100=15.6 μg/ml)与化合物6(IC100=0.0076 μg/ml)之间的对比,以及在12-O-十四酸酯phorbol 13,20-二乙酸酯(8a)(IC100=15.6 μg/ml)与12-O-十四酸酯phorbol 13-醋酸酯(8)(IC100=0.00048 μg/ml)之间的对比,除了在12-O-癸酸酯phorbol 13-(2-甲基丁酸酯)(4)和phorbol 12,13-二乙酸酯(9c)情况下。C-3碳基团的去除突然降低了对CPE的抑制,正如在3β-羟基phorbol 12,13,20-三乙酸酯(9f)(IC100=500 μg/ml)与phorbol 12,13,20-三乙酸酯(9d)(IC100=62.5 μg/ml)之间的对比所观察到的。尽管8在抑制CPE和激活PKC方面具有同等效力,但20-OH的乙酰化和4-OH的甲基化(如在8a和4-O-甲基-12-O-十四酸酯phorbol 13,20-二乙酸酯(8b)中)都急剧降低了这两种活性。另一方面,其位置异构体(12-O-乙酰phorbol 13-十四酸酯(8c)则表现出两种活性均无)。在8中去除长的酰基团导致这两种活性的显著丧失,如在phorbol 13-醋酸酯(9b)中所示。在12-O-乙酰-13-O-酰基phorbol衍生物中,6显示出对CPE的最高抑制,C-13处具有十二酸酯残基。脂肪酸碳链数量的增加和减少均导致对CPE抑制作用的显著降低。